It has been reported that CT and CRT can enhance the anti-tumor immune response through multiple mechanisms, including immunogenic tumor cell death [7,8], and Chen et al. reported that increases in peripheral CD4+ and CD8+ T cells induced by CRT are associated with superior survival in ESCC patients [27]. This evidence concerns the gene CD8A and esophageal squamous cell carcinoma.